Summary
Signal counts
Assets tracked: 2
Watchlist assets: 1
Registry stop assets: 0
Sponsor overview
University of Wisconsin, Madison
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT03943901 | https://clinicaltrials.gov/study/NCT02138214
Assets
Linked programs
- Rituximab: Watchlist Signal (2/5)
- Thyroidectomy: Low Signal (0/5)